M

Mereo BioPharma Group plc
D

MREO

2.86000
USD
-0.02
(-0.52%)
مغلق
حجم التداول
14,331
الربح لكل سهم
-0
العائد الربحي
-
P/E
-10
حجم السوق
443,716,436
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADUS
    -2.879
    (-2.57%)
    109.211 USD
    A
    ARCT
    0.846
    (5.00%)
    17.770 USD
    C
    CTRA
    -0.630
    (-2.19%)
    28.145 USD
    F
    FENC
    0.04500
    (0.68%)
    6.66500 USD
    G
    GH
    -4.510
    (-9.51%)
    42.910 USD
    J
    JAZZ
    -0.640
    (-0.47%)
    136.050 USD
    K
    KNSA
    0.320
    (1.63%)
    20.000 USD
    Z
    ZYXI
    -0.22300
    (-3.00%)
    7.20700 USD
    المزيد
الأخبار
المقالات

العنوان: Mereo BioPharma Group plc

القطاع: Healthcare
الصناعة: Biotechnology
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).